» Articles » PMID: 39915767

Innovative Nanoparticle-based Approaches for Modulating Neutrophil Extracellular Traps in Diseases: from Mechanisms to Therapeutics

Overview
Publisher Biomed Central
Date 2025 Feb 6
PMID 39915767
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophil extracellular traps (NETs) participate in both host defense and the pathogenesis of various diseases, such as infections, thrombosis, and tumors. While they help capture and eliminate pathogens, NETs' excessive or dysregulated formation can lead to tissue damage and disease progression. Therapeutic strategies targeting NET modulation have shown potential, but challenges remain, particularly in achieving precise drug delivery and maintaining drug stability. Nanoparticle (NP)-based drug delivery systems offer innovative solutions for overcoming the limitations of conventional therapies. This review explores the biological mechanisms of NET formation, their interactions with NPs, and the therapeutic applications of NP-based drug delivery systems for modulating NETs. We discuss how NPs can be designed to either promote or inhibit NET formation and provide a comprehensive analysis of their potential in treating NET-related diseases. Additionally, we address the current challenges and future prospects for NP-based therapies in NET research, aiming to bridge the gap between nanotechnology and NET modulation for the development of novel therapeutic approaches.

References
1.
Xie M, Hao Y, Feng L, Wang T, Yao M, Li H . Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke. Curr Neuropharmacol. 2022; 21(3):621-650. PMC: 10207908. DOI: 10.2174/1570159X20666220706115957. View

2.
Liu S, Liu M, Xiu J, Zhang T, Zhang B, Cun D . Celastrol-loaded bovine serum albumin nanoparticles target inflamed neutrophils for improved rheumatoid arthritis therapy. Acta Biomater. 2023; 174:345-357. DOI: 10.1016/j.actbio.2023.11.028. View

3.
Cai J, Tao H, Liu H, Hu Y, Han S, Pu W . Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells. Bioact Mater. 2023; 28:12-26. PMC: 10193170. DOI: 10.1016/j.bioactmat.2023.04.023. View

4.
Du Y, Chen Y, Li F, Mao Z, Ding Y, Wang W . Genetically Engineered Cellular Nanovesicle as Targeted DNase I Delivery System for the Clearance of Neutrophil Extracellular Traps in Acute Lung Injury. Adv Sci (Weinh). 2023; 10(32):e2303053. PMC: 10646266. DOI: 10.1002/advs.202303053. View

5.
Pisetsky D . Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2024; 76(9):1334-1343. PMC: 11349482. DOI: 10.1002/art.42863. View